Zhao et al. Nature 365:448-451 (Sep. 1993).* |
Bagnis et al., “Retroviral Transfer of the nlsLacZ Gene into Human CD34+Cell Populations and into TF-1 Cells: Future Prospects in Gene Therapy, ” Human Gene Therapy 5:1325-33 (1994). |
Doetschman et al., “Targeted mutation of the Hprt gene in mouse embryonic stem cells,” Proc. Natl. Acad. Sci. USA 85:8583-8587 (1988). |
Re et al., “Nucleotide Sequences Responsible for Generation of Internally Deleted Sendai Virus Defective Interfering Genomes,” Virology 146: 27-37 (1985). |
Baldick et al. “Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters.” J Virol Aug.;66(8):4710-9 (1992). |
Albert et al., “Antisense Knockouts: Molecular Scalpels for the Dissection of Signal Transduction”, Trends in Pharm Sci., 15:250-254, 1994. |
Gewirtz et al., “Facilitating Oligonucleotide Delivery: Helping Antisense Deliver on its Promise”, Proc. Natl. Acad. Sci. USA, 93:3161-3163, 1996. |
Grassi et al., “Ribozymes: Structure, Function and Potential Therapy for Dominant Genetic Disorders”, Ann Med, 28:499-510, 1996. |
Merker et al., “The Protein Product of the Zebrafish Homologue of the Mouse T gene is Expressed in Nuclei of the Germ Ring and the Notochord of the Early Embryo”, Development, 116:1021-1032, 1992. |
Abraham et al., “Signal transduction through the T-Cell antigen receptor,” Trends in Biochemical Sciences 17: 434-8 (1992). |
Ausubel et al. (Eds.), Current Protocols in Molecular Biology New York: John Wiley & Sons, 1994. |
Baier et al., “Construction and Characterization of ick-and fyn-Specific tRNA:Ribozyme Chimeras,” Molecular Immunology 31(12): 923-932 (1994). |
Bates et al., “Energy Coupling in Escherichia coli DNA Gyrase: the Relationship between Nucleotide Binding, Stand Passage, and DNA Supercoiling,” Biochemistry 35:1408-16 (1996). |
Bennett et al., “Selective cleavage of closely-related mRNAs by synthetic ribozymes,” Nucleic Acids Research 20(4): 831-7 (1992). |
Betrand et al., “Can hammerhead ribozymes be efficient tools to inactivate gene function”, Nucleic Acids Research 22(d): 293-300 (1994). |
Birikh et al., “The structure, function and application of the hammerhead ribozyme,” European Journal of Biochemistry 245: 1-16 (1997). |
Cameron, F. H. and P. A. Jennings, “Specific gene suppression by engineered ribozymes in monkey cells,” Proc. Natl. Acad. Sci. USA 86: 9139-9143 (1989). |
Cech, T. R., “Ribozyme engineering,” current Opinion in Structural Biology 2: 605-9 (1992). |
Chen et al. “Efficient hammerhead ribozyme and antisenses RNA targeting in a slow ribosome Escherichia coli mutant,” Nature Biotechnology 15:432-5 (1997). |
Chowrira et al., “In Vitro and In Vivo Comparison of Hammerhead, Hairpin, and Hepatitis Delta Virus Self-processing Ribozyme Cassettes,” J.Biol.Chem. 269(41): 25856-64 (1994). |
Cochran et al. “Eukaryotic transient expression system dependant on transcription factors and regulatory DNA sequences of vaccinia virus,” Proc. Natl. Acad. Sci. USA 82:19-23 (1985). |
Coffin et al. (Eds.) Retroviruses New York: Cold Spring Harbor Laboratory Press, 1997. |
Couture, L. A. and D. T. Stinchcomb, “Anti-gene therapy: the use of ribozymes to inhibit gene function,” Trends in Genetics 12(12): 510-5 (1996). |
Danos, O. and R. C. Mulligan, “Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges,” Proc. Natl. Acad. Sci. USA 85: 6460-4 (1988). |
Derwent #010354638, WPI Acc. No.: 1995-255952/199534, for German Patent Publication DE 4424762 C and PCT patent Publication WO 9601314 A2, “Ribozyme library in optimised expression cassette—comprises central hammerhead region and variable flanking regions, allows selection of optium ribozyme for specific applications”. |
Derwent #010114899, WPI Acc. No.: 1995-016150/199503, for PCT Patent Publication WO 9428152 A1, “Non-replicating adenovirus derivs.—useful as vectors for exogenous genes”. |
Derwent #010305449, WPI Acc. No.: 1995-206709/199527, for PCT Patent Publication WO 9514101 A, “New recombinant adenovirus for gene therapy of cancer—contains heterologous sequence, e.g. for thymidine kinase or a ribozyme, controlled by sequences active specifically in tumour cells”. |
Derwent #010305450, WPI Acc. No.: 1995-206710/199527, for PCT Patent Publication WO 9514102 A, “New defective adenovirus contg. gene for thymidine kinase—useful in gene therapy for treating or preventing cancer or viral infection”. |
Derwent #010642759, WPI Acc. No.: 1996-139713/199614, for PCT Patent Publciation WO 9605321 A, “Use of defective, recombinant adenovirus carrying suicide gene—for gene therapy of restenosis by transferring selected genes to smooth muscle cells of atheroscierotic plaque”. |
Fedor, M.J. and O.C. Uhlenbeck, “Substrate sequence effectson “Hammerhead” RNA catalytic efficiency,” Proc. Natl. Acad. Sci. USA 87: 1668-1672 (1990). |
Feliciello, I. and G. Chinali, “A modified alkaline lysis method for the preparation of highly purified plasmid DNA from Escherichia coli,” analytical Biochemistry 212: 394-401 (1993). |
Finer et al., “kat: A High-Efficiency Retroviral Transduction System for Primary Human T Lymphocytes,” Blood 83:(1): 43-50 (1994). |
Forster, A.C. and S. Altman, “External Guide Sequences for an RNA enzyme,” Science 249: 783-6 (1990). |
Gibson, S.A. and E.J. Shillitoe, “Ribozymes,” Molecular Biotechnology 7: 125-37 (1997). |
Goldsmith, M.A. and A. Weiss, “Isolation and characterization of a T-lymphocyte somatic mutant with altered signal transduction by the antigen receptor,” Proc. Natl. Acad. Sci. USA 84: 6879-83 (1987). |
Hahn et al., “Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation,” Proc. Natl. Acad. Sci. USA 89: 2679-83 (1992). |
Halbert et al., “Transduction by Adeno-Associated Virus Vectors in the Rabbit Airway: Efficiency, Persistance, and Readminisration,” Journal of Virolog 71(8): 5932-41 (1997). |
Hall et al., “An approach to High-Throughput Genotyping,” Genome Research 6: 781-90 (1996). |
Haseloff J. and W.L. Gerlach, “Simple RNA enzymes with new end highly specific endoribonuclease activities,” Nature 334: 85-91 (1988). |
Hofmann et al. “Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette,” Proc. Natl. Acad. Sci. USA 93: 5185-90 (1996). |
Huang, M. and J. Summers, “Infection Initiated by the RNA Pregenome of a DNA virus,” Journal of Virology 65(10): 5435-9 (1991). |
Ishizaka et al., “Isolation of Active Ribozymes from an RNA pool of Random Sequences Using an Anchored Substrate RNA,” Biochemical and Biophysical Research Communications 214(2): 403-9 (1995). |
Jayawickreme C.K. and T.A. Kost, “Gene expression systems in the development of high-throughput screens,” Current Opinion in Biotechnology 8: 629-34 (1997). |
Johnson et al., “Identification of Zinc Finger mRNAs Using Domain-Specific Differential display,” Analytical Biochemistry 236: 34-52 (1996). |
Kashani-Sabet, M and K.J. Scanlon, “Application of ribozymes to cancer gene therapy,” Cancer Gene Therapy 2(3): 213-23 (1995). |
Kawasaki et al., “Selection of the best target site for ribozyme-mediated cleavage within a fusion gene for adenovirus E1A-associated 300 kDa protein (p300) and luciferase,” Nucleic Acids Research 24(14): 3010-6 (1996). |
Keck et al., “Role of DNA Replication in Vaccinia Virus Gene Expression: A Naked Template is Required for Transcription of Three Late Trans-Activator Genes,” Cell 61: 801-9 (1990). |
Kijima et al., “Therapeutic Applications of Ribozymes,” Pharmac. Ther.68: 246-67 (1995). |
Kitamura et al., “Efficient screening of retroviral cDNA expression libraries,” Proc. Natl. Acad. Sci. USA 92: 9146-50 (1995). |
Koizimi et al., “Design of RNA enzymes distinguishing a single base mutation in RNA,” Nucleic Acids Research 17(17): 7059-7071 (1989). |
Lieber, A. and M. Strauss, “Selection of Efficient Cleavage Sites in Target RNAs by Using a Ribozyme Expression Library,” Molecular and Cellular Biology 15(1): 540-51 (1995). |
Lieber, A. and M.A. Kay, “Adenovirus-Mediated Expression of Ribozymes in Mice,” Journal of Virology 70(5): 3153-8 (1996). |
Markowitz et al., “A Safe Packaging Line for Gene Transfer: separating Viral Genes on Two Different Plasmids,” Journal of Virology 62(4): 1120-4 (1988). |
Markowitz et al., “Construction and Use of a Safe and Efficient Amphotrophic Packaging Cell Line,” Virology 167:400-6 (1988). |
McCall et al., “Minimal sequence requirements for ribozyme activity,” Proc. Natl. Acad. Sci. USA 89: 5710-4 (1992). |
Miller et al., “Cell-surface receptors for retroviruses and implications for gene transfer,” Proc. Natl. Acad. Sci. USA 93: 11407-13 (1996). |
Miller, D.G. and A.D. Miller, “A Family of Retroviruses That Utilize Related Phosphate Transporters for Cell Entry,” Journal of Virology 68(12): 8270-6 (1994). |
Miller, A.D., “Human gene therapy comes of age,” Nature 357: 455-60 (1992). |
Miller, A.D and G.J. Rosman, “Improved Retroviral Vectors for Gene Transfer,” Biotechniques 7: 980-90 (1989). |
Miller, A.D. and C. Buttimore, “Redesign of Retrovirus Packaging Cell Lines to Avoid Recombination Leading to Helper Virus Production,” Molecular and Cellular Biology 6(8(: 2895-902 (1986). |
Mizuuchi et al., “Cloning and Simplified Purification of Escherichia coli DNA Gyrase A and B Proteins,” The Journal of Biological Chemistry 25914): 9199-201 (1984). |
Murphy, F.L. and T.R. Dech, “Alternation of substrate specificity for the endoribonucleotide cleavage of RNA by the Tetrahymena ribozyme,” Proc. Natl. Acad. Sci. USA 86: 9218-22 (1989). |
Muzyczka, N., “Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells,” Current Topics in Microbiology and Immunology 158: 97-123 (1992). |
Peer et al., “Production of high-titer helper-free retroviruses by transient transfection,” Proc. Natl. Acad. Sci. USA 90: 8392-6 (1993). |
Perreault et al., “Relationship between 2′-Hydroxyls and Magnesium Binding in the Hammerhead RNA Domain: A Model for Ribozyme Catalysis,” Biochemisty 30: 4020-5 (1991). |
Perriman et al., “Extended target-site specificity for an hammerhead ribozyme,” Gene 113: 157-63 (1992). |
Peterson, F.C. and C.L. Brooks, “Identification of a Motif Associated with the Latogneic Actionsof Human Growth Hormone,” The Journal of Biological Chemistry 272(34): 21444-8 (1997). |
Rossi, J.J., “Controlled, targeted, intracellular expression of ribozymes: progress and problems,” Trends in Biotechnology 13: 301-6 (1995). |
Ruffner et al., “Sequence Requirements of the Hammerhead RNA Self-Cleavage Reaction,” Biochemistry 29: 10695-702 (1990). |
Sambrook, Fritsch, and Maniatis (Eds.) Molecular Cloning: A Laboratory Manual 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989 pp. 7.6-7.29 and 7.37-7.57. |
Samulski et al., “Helper-Free Stocks of Recombinant Adeno-Associated Viruses: Normal Integration Does Not Require Viral Gene Expression,” Journal of Virology 63(9): 3822-8 (1989). |
Schultze-Merker et al., “The protein product of the zebrafish homologue of the mouse T gene is expressed in nuclei of the germ ring and the notochord of the early embryo,” Development 116(4): 1021-33 (1992). |
Sczakiel, G., “The Design of Antisense RNA,” Antisense & Nucleic Acid Drug Development 7: 439-44 (1997). |
Shore et al., “Ribozyme-mediated cleavage of the BCRABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity,” Oncogene 8: 3183-8 (1993). |
Sigurdsson, S.T. and F. Eckstein, “Structure-function relationships of hammerhead ribozymes: form understanding to application,” Trends in Biotechnology 13: 286-9 (1995). |
Soares, M.B., “Identification and cloning of differentially expressed genes,” Current Opinion in Biotechnology 8: 542-6 (1997). |
Stoker, A.W., Chapter 6 “Retroviral vectors,” of Molecular Virology: A Practical Approach Davidson, A.J. and R.M. Elliott (Eds.) Oxford: IRL Press, 1993 pp. 171-197. |
Stone, B. and W. Wharton, “Targeted RNA fingerprinting: the cloning of differentially-expressed cDNA fragments enriched for members of the zinc finger gene family,” Nucleic Acids Research 22(13): 2612-8 (1994). |
Straus, D.B. and A. Weiss, “Genetic Evidence for the Involvement of the ICK Tyrosine Kinase in Signal Transduction through the T Cell Antigen Receptor,” Cell 70: 585-93 (1992). |
Sullenger, B.A., “Colocalizing Ribozymes with Substrate RNAs to Increase Their Efficacy as Gene Inhibitors,” Applied Biochemistry and Biotechnology 54: 57-61 (1995). |
Sullenger et al., “Expression of Chimeric tRNA-Driven Antisense Transcripts Renders NIH 3T3 Cells Highly Resistant to Moloney Murine Leukemia Virus Replication,” Molecular and Cellular Biology 10(12): 6512-23 (1990). |
Sullenger, B.A. and T.R. Cech, “Tethering Ribozymes to a Retroviral Packaging Signal for Destruction of Viral RNA,” Science 262: 1566-9 (1993). |
Sun et al., “Anti-HIV Ribozymes,” Molecular Biotechnology 7: 241-51 (1997). |
Sun et al., “Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response elements constructs,” Proc. Natl. Acad. Sci. USA 92: 7272-6 (1995). |
Uhlenbeck, O.C., “A small catalytic oligoribonucleotide,” Nature 328: 596-603 (1987). |
Von Stein et al., “A high throughput screening for rarely transcribed differentially expressed genes,” Nucleic Acids Research 25(13): 2998-602 (1997). |
Weiss et al., “Signal transduction by the T cell antigen receptor,” Seminars in Immunology 3: 313-24 (1991). |
Wyatt et al., “Replication-Deficient Vaccinia Virus Encoding Bacteriophage T7 RNA Polymerase for Transient Gene Expression in Mammalian Cells,” Virology 210: 202-5 (1995). |
Xie et al., “A ribozyme-mediated, gene “knockdown” strategy for the identification of gene functionin zebrafish,” Proc. Natl. Acad. Sci. USA 94: 13777-81 (1997). |
Xiong et al., “Sindbis Virus: An Efficient, Broad Host Range Vector for Gene Expression in Animal Cells,” Science 243: 1188-91 (1989). |
Zhao et al., “Generating loss-of-function phenotypes of the fushi tarazu gene with a targeted ribozyme in Drosophila,” Nature 365: 448-51 (1993). |
Zhou et al., “Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes,” Gene 149: 33-9 (1994). |